S'abonner

Cardiopulmonary reserve examined with cardiopulmonary exercise testing in individuals with chronic kidney disease: A systematic review and meta-analysis - 25/08/22

Doi : 10.1016/j.rehab.2021.101588 
Eva Pella a, Marieta P. Theodorakopoulou a, Afroditi K Boutou b, Maria-Eleni Alexandrou a, Dimitra-Rafailia Bakaloudi a, Despoina Sarridou c, Aristi Boulmpou d, Christodoulos Papadopoulos d, Aikaterini Papagianni a, Pantelis Sarafidis a,
a Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Greece 
b Department of Respiratory Medicine, G. Papanikolaou Hospital, Thessaloniki, Greece 
c Department of Cardiothoracic and Vascular Anaesthesia, G. Papanikolaou Hospital, Thessaloniki, Greece 
d Third Department of Cardiology, Hippokration University Hospital, Aristotle University of Thessaloniki, Greece 

Corresponding author at: Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Konstantinoupoleos 49, GR54642, Thessaloniki, Greece.Department of NephrologyHippokration Hospital, Aristotle University of ThessalonikiKonstantinoupoleos 49ThessalonikiGR54642Greece

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Abstract

Background

Patients with chronic kidney disease (CKD) often present reduced physical activity and exercise tolerance due to factors relevant to co-existing disturbances of the cardiac, nervous and muscular systems. Cardiopulmonary exercise testing (CPET) is used for clinical evaluation of exercise limitation and related symptoms (i.e., dyspnea, fatigue) in several medical fields.

Objectives

This is a systematic review and meta-analysis of studies using CPET technology to examine cardiopulmonary reserve in individuals with versus without CKD.

Methods

Literature search involved PubMed, Web of Science and Scopus databases; manual search of article references and of gray literature was also performed. Observational studies and randomized trials that used CPET for patients with CKD stage 1–5 versus controls were eligible. The primary outcome was peak oxygen uptake (VO2peak). The Newcastle-Ottawa Scale was used to evaluate the quality of retrieved studies.

Results

From an initial 4944 literature records, we identified 29 studies fulfilling the inclusion criteria; of these, 25 studies (2,213 participants) with complete data were included in the final meta-analysis. VO2peak was significantly lower in CKD patients than controls without CKD [standardized mean difference (SMD) -1.40, 95% confidence interval (CI) -1.68; -1.13)]. Values were lower for CKD than non-CKD individuals for oxygen consumption at anaerobic threshold (SMD -1.06, 95% CI -1.34; -0.79) and maximum workload [weighted mean difference (WMD) -58.26, 95% CI 74.14; -42.38]. In 3 studies, CKD patients had higher VO2peak than controls with heart failure without CKD (WMD 6.60, 95% CI 3.02; 10.18). Sensitivity analyses confirmed the robustness of these findings.

Conclusions

VO2peak and other commonly analyzed CPET variables were lower in patients with CKD than controls, which indicates reduced functional cardiopulmonary reserve in CKD. In contrast, patients with CKD performed better than controls with heart failure without CKD. Overall, rehabilitation programs should be more widely applied to individuals with CKD.

PROSPERO registration number

: CRD42021227805

Le texte complet de cet article est disponible en PDF.

Keywords : Chronic kidney disease, Cardiopulmonary exercise testing, CPET, Exercise intolerance, Cardiovascular reserve, VO2peak


Plan


© 2021  Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 65 - N° 5

Article 101588- septembre 2022 Retour au numéro
Article précédent Article précédent
  • Effect of high-intensity interval training protocols on VO2max and HbA1c level in people with type 2 diabetes: A systematic review and meta-analysis
  • Mariana Brondani de Mello, Natiele Camponogara Righi, Felipe Barreto Schuch, Luis Ulisses Signori, Antônio Marcos Vargas da Silva
| Article suivant Article suivant
  • Quadriceps weakness associated with mortality in individuals with chronic obstructive pulmonary disease
  • Thamyres Spositon, Joice M. Oliveira, Antenor Rodrigues, Jéssica Fonseca, Lais Santin, Felipe V.C. Machado, Nidia A. Hernandes, Alda Marques, Fabio Pitta, Karina C. Furlanetto

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.